Considering that IMIDs such as RA and UC are characterized by OX40/OX40L interactions occurring primarily between activated T cells and APCs within inflamed tissue (but not in peripheral blood cells), the antagonism of OX40 and OX40L represents a promising strategy for targeting areas of immune activity (Webb et al., 2016). This evidence concerns the gene TNFRSF4 and rheumatoid arthritis.